Hudson Technologies (HDSN) Insider Eric Prouty Buys 21,186 Shares

Eric Prouty, an insider, purchased 21,186 shares of HDSN on June 17, 2026. While the transaction was recorded at a zero-dollar value, it reflects an increase in Prouty's holdings. Shares of HDSN traded at approximately $5.85 on Monday.

Insider Buying and Selling at Hudson Technologies, Inc.

On June 17, 2026, several insiders, including Eric Prouty, made significant purchases of HDSN shares. Prouty bought 21,186 shares, while other insiders like Jeffrey Feeler and Nicole Bulgarino also acquired 3,219 and 31,780 shares, respectively. These transactions were not part of any pre-planned trading program.

Other Institutional Activity in HDSN

Several institutional investors have adjusted their positions in HDSN. Westerly Capital Management, LLC increased its holdings by 625,000 shares, bringing its total to 3,175,000 shares worth about $18,669,000, marking a 24.5% increase. Dimensional Fund Advisors LP added 105,160 shares, ending with 2,148,311 shares valued at approximately $12,631,109, reflecting a 5.1% increase. Conversely, Renaissance Technologies LLC reduced its stake by 193,000 shares, now holding 1,504,250 shares valued at $8,844,990, a decrease of 11.4%.

Hudson Technologies, Inc. Stock Up 13.2%

Shares of HDSN traded near $5.85 on Monday. The stock is moving within a 52-week range of $3.50 to $8.75. With its current market status, investors are keeping a close eye on its performance and future potential.

Analysts Set New Price Targets

Analysts have been active in updating their price targets for HDSN. On May 7, 2026, Canaccord Genuity maintained its 'buy' rating with a price target of $9.0. Roth Capital also upheld a 'hold' rating with an $8.0 target. Earlier, B. Riley Securities had set a target of $9.5 with a 'buy' rating. These ratings suggest a broad range of expectations for HDSN's market performance.

Bottom Line

Eric Prouty's purchase of HDSN shares is part of a broader pattern of insider buying, which can indicate confidence in the company's prospects. Institutional investors' varied actions reflect differing strategies and outlooks on HDSN's potential. Analyst ratings provide a mixed but optimistic view of the company's future performance, with price targets suggesting room for growth. As always, these insights are based on past data and do not necessarily predict future outcomes.